882803-25-0Relevant articles and documents
Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases
McBride, Christopher M.,Renhowe, Paul A.,Heise, Carla,Jansen, Johanna M.,Lapointe, Gena,Ma, Sylvia,Pineda, Ramon,Vora, Jayesh,Wiesmann, Marion,Shafer, Cynthia M.
, p. 3595 - 3599 (2007/10/03)
3-Benzimidazol-2-yl-1H-indazole analogs were developed as inhibitors of receptor tyrosine kinases (RTK). The synthesis and SAR of this series is reported.